Next Article in Journal
The Brassinosteroid Signaling Pathway—New Key Players and Interconnections with Other Signaling Networks Crucial for Plant Development and Stress Tolerance
Next Article in Special Issue
Effects of (−)-Gallocatechin-3-Gallate on Tetrodotoxin-Resistant Voltage-Gated Sodium Channels in Rat Dorsal Root Ganglion Neurons
Previous Article in Journal
Surgical Resection of Brain Metastases—Impact on Neurological Outcome
Previous Article in Special Issue
Combinatorial Analysis of Secretory Immunoglobulin A (sIgA) Expression in Plants
Due to scheduled maintaince work on one of the switches in our server center, our websites and may experience short service dirsuptions of up to 5 minutes on 30 January 2015 00:00 PM EST time.
Int. J. Mol. Sci. 2013, 14(5), 8719-8739; doi:10.3390/ijms14058719

Improving Pharmaceutical Protein Production in Oryza sativa

, 1,2
, 1
, 1
, 1
, 2
 and 1,*
Received: 21 January 2013 / Revised: 14 April 2013 / Accepted: 15 April 2013 / Published: 24 April 2013
(This article belongs to the Special Issue Plant-Derived Pharmaceuticals by Molecular Farming 2012)
View Full-Text   |   Download PDF [247 KB, uploaded 19 June 2014]
Abstract: Application of plant expression systems in the production of recombinant proteins has several advantages, such as low maintenance cost, absence of human pathogens, and possession of complex post-translational glycosylation capabilities. Plants have been successfully used to produce recombinant cytokines, vaccines, antibodies, and other proteins, and rice (Oryza sativa) is a potential plant used as recombinant protein expression system. After successful transformation, transgenic rice cells can be either regenerated into whole plants or grown as cell cultures that can be upscaled into bioreactors. This review summarizes recent advances in the production of different recombinant protein produced in rice and describes their production methods as well as methods to improve protein yield and quality. Glycosylation and its impact in plant development and protein production are discussed, and several methods of improving yield and quality that have not been incorporated in rice expression systems are also proposed. Finally, different bioreactor options are explored and their advantages are analyzed.
Keywords: bioreactor; glycosylation; inducible system; Oryza sativa; recombinant protein; suspension cells; transgenic plants bioreactor; glycosylation; inducible system; Oryza sativa; recombinant protein; suspension cells; transgenic plants
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |

MDPI and ACS Style

Kuo, Y.-C.; Tan, C.-C.; Ku, J.-T.; Hsu, W.-C.; Su, S.-C.; Lu, C.-A.; Huang, L.-F. Improving Pharmaceutical Protein Production in Oryza sativa. Int. J. Mol. Sci. 2013, 14, 8719-8739.

AMA Style

Kuo Y-C, Tan C-C, Ku J-T, Hsu W-C, Su S-C, Lu C-A, Huang L-F. Improving Pharmaceutical Protein Production in Oryza sativa. International Journal of Molecular Sciences. 2013; 14(5):8719-8739.

Chicago/Turabian Style

Kuo, Yu-Chieh; Tan, Chia-Chun; Ku, Jung-Ting; Hsu, Wei-Cho; Su, Sung-Chieh; Lu, Chung-An; Huang, Li-Fen. 2013. "Improving Pharmaceutical Protein Production in Oryza sativa." Int. J. Mol. Sci. 14, no. 5: 8719-8739.

Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert